S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Compare Stocks

Date Range: 

 AbiomedTeleflexNovoCureInsuletHill-Rom
SymbolNASDAQ:ABMDNYSE:TFXNASDAQ:NVCRNASDAQ:PODDNYSE:HRC
Price Information
Current Price$300.63$305.22$82.06$263.17$155.68
50-Day Moving Average$340.14$349.68$108.28$298.62$153.61
52-Week Low$254.41$289.00$81.38$218.28$93.34
52-Week High$387.40$449.38$232.76$324.81$156.22
MarketRank™
Overall Score2.22.82.32.12.5
Analysis Score2.13.53.13.31.1
Community Score4.54.14.54.74.4
Dividend Score0.01.70.00.03.3
Ownership Score2.53.33.30.82.5
Earnings & Valuation Score1.91.30.61.91.3
Analyst Ratings
Consensus RecommendationHoldBuyHoldBuyHold
Consensus Price Target$363.75$445.20$180.43$311.20$144.00
% Upside from Price Target21.00% upside45.86% upside119.87% upside18.25% upside-7.50% downside
Trade Information
Market Cap$13.68 billion$14.30 billion$8.52 billion$18.15 billion$10.28 billion
Beta1.271.080.970.660.55
Average Volume259,046273,840745,034429,744658,643
Sales & Book Value
Annual Revenue$847.52 million$2.54 billion$494.37 million$904.40 million$3.02 billion
Price / Sales16.145.6417.2320.073.41
Cashflow$5.31 per share$14.26 per share$0.23 per share$0.79 per share$9.28 per share
Price / Cash56.6121.40353.03333.4816.77
Book Value$30.43 per share$78.08 per share$3.98 per share$7.22 per share$28.46 per share
Price / Book9.883.9120.6236.455.47
Profitability
Net Income$225.52 million$335.32 million$19.81 million$6.80 million$248.50 million
EPS$3.24$9.15($0.27)($0.45)$3.72
Trailing P/E Ratio92.7933.36N/AN/A41.85
Forward P/E Ratio60.0121.34N/A175.4521.36
P/E Growth3.69N/AN/AN/AN/A
Net Margins15.32%15.71%-4.94%-2.84%8.23%
Return on Equity (ROE)15.80%17.78%-6.50%0.63%23.07%
Return on Assets (ROA)14.12%8.70%-2.49%0.18%8.96%
Dividend
Annual PayoutN/A$1.36N/AN/A$0.96
Dividend YieldN/A0.45%N/AN/A0.62%
Three-Year Dividend GrowthN/AN/AN/AN/A22.22%
Payout RatioN/A14.86%N/AN/A25.81%
Years of Consecutive Dividend GrowthN/AN/AN/AN/A11 Years
Debt
Debt-to-Equity RatioN/A0.531.362.520.97
Current Ratio7.642.748.585.721.38
Quick Ratio6.891.888.404.951.05
Ownership Information
Institutional Ownership Percentage90.52%94.65%75.45%N/A76.45%
Insider Ownership Percentage3.00%1.34%5.07%1.00%0.69%
Miscellaneous
Employees1,72514,0001,0231,90010,000
Shares Outstanding45.50 million46.85 million103.82 million68.97 million66.05 million
Next Earnings Date1/27/2022 (Estimated)2/24/2022 (Estimated)2/24/2022 (Estimated)2/22/2022 (Estimated)2/4/2022 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Shareholder Alert: The M&A Firm is Investigating the Merger of ACBI, DSPG, HRC, ADTN, and HOMB - PRNewswireShareholder Alert: The M&A Firm is Investigating the Merger of ACBI, DSPG, HRC, ADTN, and HOMB - PRNewswire
prnewswire.com - December 5 at 5:53 PM
‘Tis the Season! All the Christmas Movies Starring ‘One Tree Hill’ Alumni: A Complete Guide - Us Weekly‘Tis the Season! All the Christmas Movies Starring ‘One Tree Hill’ Alumni: A Complete Guide - Us Weekly
usmagazine.com - December 5 at 12:53 PM
An Hill-Rom Holdings Inc. (HRC) SVP, Corp. Dev., Strat. & IR Sells 2018.0 Shares - The Fosters LeaderAn Hill-Rom Holdings Inc. (HRC) SVP, Corp. Dev., Strat. & IR Sells 2018.0 Shares - The Fosters Leader
fostersleader.com - December 4 at 3:05 PM
Analysts Offer Insights on Healthcare Companies: Cooper Co (NYSE: COO) and Surgery Partners (NASDAQ: SGRY) - Analyst RatingsAnalysts Offer Insights on Healthcare Companies: Cooper Co (NYSE: COO) and Surgery Partners (NASDAQ: SGRY) - Analyst Ratings
analystratings.com - December 3 at 11:52 PM
Shareholder Alert: The M&A Firm is Investigating the Merger of ACBI, DSPG, HRC, ADTN, and HOMB - Kilgore News HeraldShareholder Alert: The M&A Firm is Investigating the Merger of ACBI, DSPG, HRC, ADTN, and HOMB - Kilgore News Herald
kilgorenewsherald.com - December 3 at 11:52 PM
Medical Videoscope Market 2021: Expeditious Growth Expected In Coming Years - EIN NewsMedical Videoscope Market 2021: Expeditious Growth Expected In Coming Years - EIN News
einnews.com - December 3 at 1:51 PM
[2021-2028] Nurse Call Systems Market to Reach USD 2.79 Billion | Nurse Call Systems Industry Size, Share, Growth Factors & Forecast - Yahoo Sports[2021-2028] Nurse Call Systems Market to Reach USD 2.79 Billion | Nurse Call Systems Industry Size, Share, Growth Factors & Forecast - Yahoo Sports
sports.yahoo.com - December 3 at 1:51 PM
HILL-ROM HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K) - marketscreener.comHILL-ROM HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K) - marketscreener.com
marketscreener.com - December 3 at 1:51 PM
Hillrom Shareholders Approve Acquisition By Baxter | News | wfmz.com - WFMZ AllentownHillrom Shareholders Approve Acquisition By Baxter | News | wfmz.com - WFMZ Allentown
wfmz.com - December 3 at 8:51 AM
BAXTER INTERNATIONAL INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K) - marketscreener.comBAXTER INTERNATIONAL INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K) - marketscreener.com
marketscreener.com - December 3 at 12:46 AM
The global ECG equipment market is projected to register a CAGR of 5.57% during the forecast period, 2021-2028 - Yahoo FinanceThe global ECG equipment market is projected to register a CAGR of 5.57% during the forecast period, 2021-2028 - Yahoo Finance
finance.yahoo.com - December 2 at 7:46 PM
Fitch Assigns ICU Medical BB (EXP) Long-Term IDR; Outlook Stable - Fitch RatingsFitch Assigns ICU Medical 'BB' (EXP) Long-Term IDR; Outlook Stable - Fitch Ratings
fitchratings.com - December 2 at 7:46 PM
Hill-Rom Logo. (PRNewsFoto/Hill-Rom Holdings, Inc.) (PRNewsFoto/) (PRNewsfoto/Hill-Rom Holdings, Inc.) | News | mdjonline.com - MDJOnline.comHill-Rom Logo. (PRNewsFoto/Hill-Rom Holdings, Inc.) (PRNewsFoto/) (PRNewsfoto/Hill-Rom Holdings, Inc.) | News | mdjonline.com - MDJOnline.com
mdjonline.com - December 2 at 7:46 PM
Hill-Rom Logo. (PRNewsFoto/Hill-Rom Holdings, Inc.) (PRNewsFoto/) (PRNewsfoto/Hill-Rom Holdings, Inc.) | News | wfmz.com - WFMZ AllentownHill-Rom Logo. (PRNewsFoto/Hill-Rom Holdings, Inc.) (PRNewsFoto/) (PRNewsfoto/Hill-Rom Holdings, Inc.) | News | wfmz.com - WFMZ Allentown
wfmz.com - December 2 at 7:46 PM
[2021-2028] Nurse Call Systems Market to Reach USD 2.79 Billion | Nurse Call Systems Industry Size, Share, Growth Factors & Forecast - Yahoo Finance[2021-2028] Nurse Call Systems Market to Reach USD 2.79 Billion | Nurse Call Systems Industry Size, Share, Growth Factors & Forecast - Yahoo Finance
finance.yahoo.com - December 2 at 9:46 AM
Flora Collins Obituary (1934 - 2021) - Connersville, IN - Connersville News Examiner - Legacy.comFlora Collins Obituary (1934 - 2021) - Connersville, IN - Connersville News Examiner - Legacy.com
legacy.com - December 1 at 11:51 PM
Hospital Furniture Market to Reach Valuation of US$ 16.1 Bn by 2030; Furniture Manufacturers Focusing on Ergonomics, Patients Comfort & Safety, and Environmental Friendliness: TMR Study - PRNewswireHospital Furniture Market to Reach Valuation of US$ 16.1 Bn by 2030; Furniture Manufacturers Focusing on Ergonomics, Patient's Comfort & Safety, and Environmental Friendliness: TMR Study - PRNewswire
prnewswire.com - December 1 at 1:29 PM
Mobile Cardiac Telemetry Systems Market to grow by USD 424.19 million | Evolving Opportunities with ACS Diagnostics Inc. & BioTelemetry Inc. | 17000+ Technavio Reports - Yahoo FinanceMobile Cardiac Telemetry Systems Market to grow by USD 424.19 million | Evolving Opportunities with ACS Diagnostics Inc. & BioTelemetry Inc. | 17000+ Technavio Reports - Yahoo Finance
finance.yahoo.com - December 1 at 8:29 AM
Ambulatory Cardiac Monitor Sales market players to make profitable investments during 2021-2027 - Northwest Diamond NotesAmbulatory Cardiac Monitor Sales market players to make profitable investments during 2021-2027 - Northwest Diamond Notes
nwdiamondnotes.com - December 1 at 12:51 AM
Infrared Thermometers Market To Surpass US$ 1.3 Bn By 2031, With Mandatory Temperature Screening considered as Safety Standards - PRNewswireInfrared Thermometers Market To Surpass US$ 1.3 Bn By 2031, With Mandatory Temperature Screening considered as Safety Standards - PRNewswire
prnewswire.com - November 30 at 9:50 AM
Mobile Cardiac Telemetry Systems Market to grow by USD 424.19 million | Evolving Opportunities with ACS Diagnostics Inc. & BioTelemetry Inc. | 17000+ Technavio Reports - KPVI News 6Mobile Cardiac Telemetry Systems Market to grow by USD 424.19 million | Evolving Opportunities with ACS Diagnostics Inc. & BioTelemetry Inc. | 17000+ Technavio Reports - KPVI News 6
kpvi.com - November 29 at 11:43 PM
Cardiac Arrhythmia Monitoring Devices Market To Witness the Highest Growth Globally in Coming Years 2020-2030 - EIN NewsCardiac Arrhythmia Monitoring Devices Market To Witness the Highest Growth Globally in Coming Years 2020-2030 - EIN News
einnews.com - November 29 at 1:32 PM
Blood Pressure Cuffs Market Is Likely To Experience A Tremendous Growth In Near Future 2020-2030 - EIN NewsBlood Pressure Cuffs Market Is Likely To Experience A Tremendous Growth In Near Future 2020-2030 - EIN News
einnews.com - November 29 at 1:32 PM
Global ENT Devices Market Report 2021 with CAGR Projections through 2026 - Benzinga - BenzingaGlobal ENT Devices Market Report 2021 with CAGR Projections through 2026 - Benzinga - Benzinga
benzinga.com - November 29 at 8:31 AM
How has COVID-19 Impacted the Hospital Supplies Industry? : Report Fact.MR - BioSpaceHow has COVID-19 Impacted the Hospital Supplies Industry? : Report Fact.MR - BioSpace
biospace.com - November 29 at 3:31 AM
DateCompanyBrokerageAction
11/8/2021InsuletRaymond James
Boost Price Target
11/5/2021InsuletMorgan Stanley
Boost Price Target
11/5/2021InsuletSVB Leerink
Boost Price Target
11/5/2021InsuletCanaccord Genuity
Boost Price Target
11/5/2021InsuletCitigroup
Boost Price Target
11/5/2021InsuletPiper Sandler
Boost Price Target
11/5/2021Hill-RomStifel Nicolaus
Downgrade
10/31/2021AbiomedSVB Leerink
Reiterated Rating
10/29/2021TeleflexMorgan Stanley
Lower Price Target
10/29/2021TeleflexRaymond James
Lower Price Target
10/29/2021TeleflexJMP Securities
Lower Price Target
10/25/2021NovoCurePiper Sandler
Lower Price Target
9/19/2021Hill-RomMorgan Stanley
Downgrade
9/10/2021TeleflexJefferies Financial Group
Initiated Coverage
9/8/2021Hill-RomKeyCorp
Downgrade
9/7/2021TeleflexRaymond James
Initiated Coverage
9/3/2021Hill-RomRobert W. Baird
Downgrade
8/10/2021Hill-RomBank of America
Downgrade
8/6/2021AbiomedSVB Leerink
Boost Price Target
8/6/2021AbiomedDeutsche Bank Aktiengesellschaft
Boost Price Target
8/6/2021InsuletSVB Leerink
Lower Price Target
8/6/2021InsuletCanaccord Genuity
Boost Price Target
8/6/2021InsuletCitigroup
Boost Price Target
8/2/2021TeleflexKeyCorp
Lower Price Target
8/2/2021Hill-RomMorgan Stanley
Boost Price Target
8/2/2021Hill-RomRobert W. Baird
Boost Price Target
8/2/2021Hill-RomKeyCorp
Boost Price Target
7/30/2021TeleflexJMP Securities
Reiterated Rating
7/30/2021TeleflexSVB Leerink
Boost Price Target
7/30/2021NovoCureWells Fargo & Company
Lower Price Target
7/30/2021NovoCureMizuho
Lower Price Target
7/29/2021NovoCurePiper Sandler
Reiterated Rating
7/21/2021InsuletCowen
Boost Price Target
7/20/2021AbiomedSVB Leerink
Lower Price Target
7/20/2021InsuletSVB Leerink
Boost Price Target
7/19/2021TeleflexSVB Leerink
Downgrade
7/9/2021TeleflexNeedham & Company LLC
Initiated Coverage
7/9/2021NovoCurePiper Sandler
Boost Price Target
7/1/2021NovoCureNorthland Securities
Initiated Coverage
7/1/2021NovoCureMizuho
Downgrade
6/18/2021AbiomedDeutsche Bank Aktiengesellschaft
Initiated Coverage
6/6/2021AbiomedSVB Leerink
Reiterated Rating
6/2/2021TeleflexJefferies Financial Group
Reiterated Rating
5/24/2021InsuletBarclays
Initiated Coverage
5/23/2021TeleflexSVB Leerink
Reiterated Rating
5/7/2021InsuletRaymond James
Lower Price Target
5/7/2021InsuletSVB Leerink
Lower Price Target
5/7/2021InsuletPiper Sandler
Lower Price Target
5/7/2021InsuletBTIG Research
Reiterated Rating
5/3/2021Hill-RomRaymond James
Boost Price Target
5/3/2021Hill-RomRobert W. Baird
Boost Price Target
4/30/2021TeleflexMorgan Stanley
Boost Price Target
4/30/2021TeleflexSVB Leerink
Boost Price Target
4/20/2021NovoCureWedbush
Reiterated Rating
4/19/2021NovoCureTruist
Boost Price Target
4/19/2021NovoCureTruist Securities
Boost Price Target
4/14/2021NovoCureNorthland Securities
Boost Price Target
4/14/2021NovoCureWedbush
Downgrade
4/14/2021NovoCureMizuho
Boost Price Target
4/13/2021NovoCureWells Fargo & Company
Boost Price Target
4/1/2021InsuletSVB Leerink
Upgrade
3/19/2021InsuletCanaccord Genuity
Upgrade
3/12/2021TeleflexRaymond James
Boost Price Target
3/2/2021InsuletSVB Leerink
Boost Price Target
3/1/2021NovoCureMizuho
Boost Price Target
2/26/2021TeleflexRaymond James
Boost Price Target
2/25/2021TeleflexPiper Sandler
Reiterated Rating
2/25/2021InsuletOppenheimer
Boost Price Target
2/24/2021InsuletSVB Leerink
Reiterated Rating
2/24/2021InsuletRaymond James
Boost Price Target
2/16/2021Hill-RomRaymond James
Boost Price Target
2/8/2021Hill-RomRaymond James
Boost Price Target
2/8/2021Hill-RomMorgan Stanley
Boost Price Target
2/8/2021Hill-RomRobert W. Baird
Boost Price Target
2/1/2021InsuletBTIG Research
Reiterated Rating
1/29/2021AbiomedSVB Leerink
Boost Price Target
1/29/2021AbiomedMorgan Stanley
Boost Price Target
1/29/2021NovoCureTruist
Boost Price Target
1/29/2021InsuletPiper Sandler
Downgrade
1/28/2021AbiomedPiper Sandler
Boost Price Target
1/27/2021TeleflexJMP Securities
Boost Price Target
1/25/2021NovoCurePiper Sandler
Boost Price Target
1/15/2021InsuletWells Fargo & Company
Reiterated Rating
1/12/2021NovoCureWedbush
Boost Price Target
1/11/2021TeleflexWells Fargo & Company
Boost Price Target
1/8/2021TeleflexKeyCorp
Boost Price Target
1/6/2021TeleflexNeedham & Company LLC
Boost Price Target
12/21/2020AbiomedSVB Leerink
Boost Price Target
12/15/2020AbiomedMorgan Stanley
Boost Price Target
12/15/2020TeleflexMorgan Stanley
Boost Price Target
12/15/2020TeleflexUBS Group
Boost Price Target
12/15/2020TeleflexSVB Leerink
Boost Price Target
12/15/2020Hill-RomMorgan Stanley
Boost Price Target
12/3/2020TeleflexRaymond James
Boost Price Target
11/9/2020Hill-RomRaymond James
Boost Price Target
11/4/2020Hill-RomNeedham & Company LLC
Downgrade
10/30/2020NovoCureMizuho
Boost Price Target
10/29/2020NovoCurePiper Sandler
Boost Price Target
10/12/2020AbiomedSVB Leerink
Lower Price Target
10/12/2020Hill-RomRaymond James
Lower Price Target
10/1/2020Hill-RomKeyCorp
Lower Price Target
9/29/2020Hill-RomNeedham & Company LLC
Lower Price Target
9/23/2020NovoCureNorthland Securities
Initiated Coverage
9/21/2020Hill-RomMorgan Stanley
Lower Price Target
9/18/2020NovoCureWells Fargo & Company
Downgrade
9/17/2020NovoCurePiper Sandler
Boost Price Target
9/17/2020NovoCureTruist
Downgrade
9/16/2020Hill-RomRaymond James
Reiterated Rating
9/1/2020Hill-RomRobert W. Baird
Initiated Coverage
8/7/2020AbiomedMorgan Stanley
Boost Price Target
8/7/2020AbiomedSVB Leerink
Boost Price Target
8/3/2020NovoCureSunTrust Banks
Reiterated Rating
8/3/2020Hill-RomMorgan Stanley
Lower Price Target
8/3/2020Hill-RomRaymond James
Lower Price Target
7/13/2020AbiomedOTR Global
Upgrade
5/28/2020AbiomedSVB Leerink
Boost Price Target
5/27/2020AbiomedBTIG Research
Downgrade
5/1/2020AbiomedMorgan Stanley
Boost Price Target
4/27/2020AbiomedSVB Leerink
Downgrade
3/27/2020AbiomedMorgan Stanley
Lower Price Target
3/23/2020AbiomedPiper Sandler
Reiterated Rating
3/23/2020AbiomedStephens
Lower Price Target
2/11/2020AbiomedMorgan Stanley
Downgrade
2/6/2020AbiomedBTIG Research
Initiated Coverage
12/17/2019AbiomedMorgan Stanley
Lower Price Target
(Data available from 12/6/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.